UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000039846
Receipt number R000045434
Scientific Title Examination of advanced dental technology with EMDOGAIN gel in periodontal regenerative therapy
Date of disclosure of the study information 2020/03/20
Last modified on 2020/03/17 12:13:10

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Examination of advanced dental technology with EMDOGAIN gel in periodontal regenerative therapy

Acronym

Examination of advanced dental technology with EMDOGAIN gel in periodontal regenerative therapy

Scientific Title

Examination of advanced dental technology with EMDOGAIN gel in periodontal regenerative therapy

Scientific Title:Acronym

Examination of advanced dental technology with EMDOGAIN gel in periodontal regenerative therapy

Region

Japan


Condition

Condition

periodontitis

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

A growing amount of evidence indicates that enamel matrix protein is effective for periodontal regenerative therapy. The purpose of this study is to evaluate the clinical outcomes of the periodontal regenerative therapy using EMDOGAIN, which is gel preparation containing emanel matrix protein.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Probing pocket depth, clinical attachment level, width of keratinized gingiva and the amount of radiographical bone formation

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Periodontal regeneration therapy using EMDOGAIN is performed for subjects who are diagnosed as needing periodontal regeneration therapy.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

100 years-old >

Gender

Male and Female

Key inclusion criteria

1. Chronic periodontitis patients who visits Tokyo Medical and Dental University Hospital and plans to receive periodontal regenerative therapy using EMDGAIN
2. Patients who gave informed consent
3. 20 years old or more

Key exclusion criteria

1. Systemic diseases which might affect periodontitis
2. Subjects who are judged to lack the ability to give informed consent

Target sample size

600


Research contact person

Name of lead principal investigator

1st name Koji
Middle name
Last name Mizutani

Organization

Tokyo Medical and Dental University

Division name

Department of periodontology

Zip code

113-8510

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

0358035488

Email

mizuperi@tmd.ac.jp


Public contact

Name of contact person

1st name Koji
Middle name
Last name Mizutani

Organization

Tokyo Medical and Dental University

Division name

Department of periodontology

Zip code

113-8510

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo

TEL

0358035488

Homepage URL


Email

mizuperi@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical and Dental University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical and Dental University

Address

1-5-45, Yushima, Bunkyo-ku, Tokyo, Japan

Tel

0358035488

Email

mizuperi@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

東京医科歯科大学歯学部附属病院


Other administrative information

Date of disclosure of the study information

2020 Year 03 Month 20 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

538

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2010 Year 03 Month 17 Day

Date of IRB

2010 Year 03 Month 17 Day

Anticipated trial start date

2010 Year 04 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2020 Year 03 Month 17 Day

Last modified on

2020 Year 03 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000045434


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name